Management of Diabetes in Organ Transplant Patients / 임상당뇨병
Journal of Korean Diabetes
;
: 134-141, 2014.
Artículo
en Coreano
| WPRIM
| ID: wpr-726972
ABSTRACT
New onset diabetes after transplantation (NODAT) is a common complication after solid-organ transplantation and is associated with increased cardiovascular morbidity, mortality, and graft loss. The risk factors for NODAT include older age, ethnicity, genetic factors,obesity, family history of diabetes, hepatitis C virus infection, and immunosuppressant use (corticosteroids, calcineurin inhibitors, and mTOR inhibitor). Management of NODAT must be considered at the pre-transplantation stage in order to properly screen high-risk patients. Although NODAT management is similar to that of general type 2 diabetes, some specific considerations must be made in NODAT management, including the interactions between anti-diabetes medication and immunosuppressive agents.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Factores de Riesgo
/
Mortalidad
/
Trasplante de Órganos
/
Hepacivirus
/
Calcineurina
/
Trasplantes
/
Diabetes Mellitus
/
Diagnóstico
/
Inmunosupresores
Tipo de estudio:
Estudio diagnóstico
/
Estudio de etiología
/
Estudio pronóstico
/
Factores de riesgo
Límite:
Humanos
Idioma:
Coreano
Revista:
Journal of Korean Diabetes
Año:
2014
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS